These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8389069)

  • 41. The role of osteopontin on calcium oxalate crystal formation.
    Konya E; Umekawa T; Iguchi M; Kurita T
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.
    Berg C; Tiselius HG
    Urol Res; 1989; 17(3):167-72. PubMed ID: 2546314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of citrate complexes in preventing urolithiasis.
    Ashby RA; Sleet RJ
    Clin Chim Acta; 1992 Sep; 210(3):157-65. PubMed ID: 1468138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of an in vitro assay for the screening of substances capable of dissolving calcium oxalate crystals.
    Saso L; Valentini G; Leone MG; Grippa E; Silvestrini B
    Urol Int; 1998; 61(4):210-4. PubMed ID: 10364751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cooperative effects of Na
    Shanthil M; Sandeep K; Sajith PK
    Phys Chem Chem Phys; 2020 Feb; 22(8):4788-4792. PubMed ID: 32068201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques.
    Baumann JM; Wacker M
    Urol Res; 1979 Sep; 7(3):183-8. PubMed ID: 228455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K; Umekawa T; Katayama Y; Ishikawa Y; Kodama M; Takamura C; Takada M; Kato Y; Hohri K; Iguchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
    Kavanagh JP; Jones L; Rao PN
    Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The inhibitory activity of some citrate analogues upon calcium crystalluria: observations using an improved urine evaporation technique.
    Hallson PC; Kasidas GP; Samuell CT
    Urol Int; 1996; 57(1):43-7. PubMed ID: 8840490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of agglomeration in calcium oxalate monohydrate urolith development.
    Grases F; Millan A; Söhnel O
    Nephron; 1992; 61(2):145-50. PubMed ID: 1630537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Yoshioka T; Koide T; Okuyama A
    Urol Res; 1998; 26(3):209-13. PubMed ID: 9694604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells.
    Grover PK; Thurgood LA; Fleming DE; van Bronswijk W; Wang T; Ryall RL
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F355-61. PubMed ID: 18077596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro formation of "urinary stones": generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization.
    Achilles W; Jöckel U; Schaper A; Burk M; Riedmiller H
    Scanning Microsc; 1995 Jun; 9(2):577-85; discussion 585-6. PubMed ID: 8714750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of inhibitors on the crystal growth of calcium oxalate.
    Minero C; Maggiorotti P; Barbeni M; Pelizzetti E; Tizzani A; Casetta G; Piana P; Giona C
    Contrib Nephrol; 1987; 58():65-72. PubMed ID: 3691149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.